Armata Pharmaceuticals | 10-Q:季度報表
Armata Pharmaceuticals | 8-K:Armata Pharmaceuticals公佈2024年第一季度業績並提供公司最新情況
Armata Pharmaceuticals | ARS:年度報告
Armata Pharmaceuticals | DEF 14A:股東委託書決議
Armata Pharmaceuticals | 8-K:重大事件
Armata Pharmaceuticals | 10-K:年度報表
Armata Pharmaceuticals | 8-K:Armata Pharmicals公佈2023年第四季度和全年業績並提供公司最新情況
Armata Pharmaceuticals | 4:持股變動聲明-董事 PATTI JOSEPH M
Armata Pharmaceuticals | 4:持股變動聲明-董事 Kramer Robin
Armata Pharmaceuticals | 4:持股變動聲明-董事 Peterson Todd C.
Armata Pharmaceuticals | 4:持股變動聲明-高管 Rychlik Richard
Armata Pharmaceuticals | 4:持股變動聲明-董事 Schlesinger Sarah J.
Armata Pharmaceuticals | 4:持股變動聲明-董事 Haimovitz Jules
Armata Pharmaceuticals | 4:持股變動聲明-董事 Odysseas Kostas D
Armata Pharmaceuticals | 4:持股變動聲明-高管 Birx Deborah
Armata Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Innoviva, Inc(85.3%),Innoviva Strategic Opportunities LLC(62.1%)
Armata Pharmaceuticals | 8-K:重大事件
Armata Pharmaceuticals | S-8:員工福利計劃證券登記
Armata Pharmaceuticals | 4:持股變動聲明-董事 Schlesinger Sarah J.
Armata Pharmaceuticals | 4:持股變動聲明-董事 Peterson Todd C.
暫無數據